Clorox (CLX) Tops Q2 EPS by 15c, Updates FY Guidance

Clorox (NYSE: CLX) reported Q2 EPS of $1.46, $0.15 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Clorox sees FY2020 EPS of $6.10-$6.25, versus the consensus of $6.14.

• Low single-digit decrease to 1% increase in sales (flat to 2% organic sales growth)
• $6.10-$6.25 diluted EPS range (3% to 1% decrease versus year-ago)

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• United Natural Foods (UNFI) Reports In-Line Q3 EPS ; Offers Outlook
• Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance